Optic nerve sheath meningioma. Experience in Lyon with twenty patients;Méningiome du nerf optique. L'expérience lyonnaise

Revue Neurologique

Volumn 163, Issue 5, 2007, Pages 549-559

  Mouton, S ^a   Tilikete, C ^a   Bernard, M ^a   Krolak Salmon, P ^a   Vighetto, A ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Benign; Conformal radiotherapy; Intracranial meningioma; Intraorbitar meningioma; Optic nerve sheath tumors

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EYE EXAMINATION; EYE FUNDUS; FEMALE; FUNCTIONAL ASSESSMENT; GOLD STANDARD; HUMAN; MALE; MENINGIOMA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; PROGNOSIS; VISUAL ACUITY; VISUAL DISORDER; VISUAL FIELD;

EID: 34249869279     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(07)90461-0     Document Type: Article

References (54)

1. ANDREWS DW, FAROOZAN R, YANG BP. (2002). Fractinated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgery. Neurosurg, 51: 590-904.
2. BAUMERT BG et al. (2004). Early improvements in vision after fractionated stereotactic radiotherapy for primary optic nerve sheath meningioma. Radiother Oncol, 72(2): 169-174.
3. BECKER G, JEREMIC B, PITZ S et al. (2002). Stereotactic fractionated radiotherapy in patients with optic nerve sheath meningioma. Int J Radiation Oncology Biol Phys, 54(5): 1422-1429.
4. BICKERSTAFF ER, SMALL FY, GUEST JA. (1958). The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatry, 21: 84-91.
5. BONDY ML, WRENSCH MR. (1996). Epidemiolgy of primary malignant brain tumours. Bailliere Clin Neurol, 5: 251-270.
6. CARROL RS, GLOWACKA D, DASHNER K, BLACK PM. (1993). Progesterone receptor expression in méningiomas. Cancer Res, 53: 1312-1316.
7. DANIELS DL, HERFKINS R, GAGER WE et al. (1984). Magnetic resonance imaging of the optic nerves and chiasm. Radiology, 152(1): 79-83.
8. DELFINI R et al. (1996). Primary benign tumors of the orbital cavity: comparative data in a series of patients with optic nerve glioma, sheath meningioma, or neurinoma. Surg Neurol, 45(2): 147-53; discussion 153-154.
9. DUTTON JJ, ANDERSON RL. (1985). Idiopathic inflammatory perioptic neuritis simulating optic nerve sheath meningioma. Am J Ophtalmol, 100(3): 424-430.
10. DUTTON JJ. (1992). Optic nerve sheath méningiomas. Surv Ophtalmol, 37(3): 167-183.
11. EGAN RA, LESSEL S. (2002). A contribution to the natural history of optic nerve sheath meningiomas. Arch Ophtalmol, 120(11): 1505-1508.
12. FINEMAN MS, AUGSBURGER JJ. (1999). A new approach to an old problem. Surv Ophtalmol 43: 519-524.
13. FRISEN L, HOYT WF, TENGROTH BM. (1973).Optociliary veins, disc pallor and visual loss:a triad of signs indicating spheno-orbital meningiomas. Acta Ophtalmol, 57: 241-249.
14. GRUNBERG SM, WEISS MH, SPITZ IM et al. (1991). Treatment of unresectable méningiomes with the antiprogesterone agent mifepristone. J Neurosurg, 74(6): 861-866.
15. HAMPTON GR, KROHEL GB. (1983). Gase-evoked blindness. Ann Ophtalmol, 15(1): 73-76.
16. HART WM, BURDE RM, KLINGELE TG, PERLMUTTER JC. (1980). Bilateral optic nerve sheath meningiomas. Arch Ophthalmol, 98(1): 149-151.
17. ITO M, ISHIZAWA A, MIYAOKA M, SATO K, ISHII S. (1988). Intraorbital meningiomas. Surgical management and role of radiation therapy. Surg Neurol, 29(6): 448-453.
18. JOHNS TT, CITRIN CM, BLACK J, SHERMAN JL. (1984). CT evaluation of perineural orbital lesions: evaluation of the "tram-tracking" sign. AJNR, 5(5): 587-590.
19. KENNERDELL JS, MAROON JC, MALTON M, WARREN FA. (1988). The management of optic nerve sheath meningiomas. Am J Ophtalmol, 106(4): 450-457.
20. KIM JW, RIZZO JF, LESSELL S. (2005). Controversies in the management of optic nerve sheath meningiomas. Int Ophthalmol Clin Fall, 45(4): 15-23.
21. KLINK DF, MILLER NR, WILLIAMS J. (1998). Preservation of residual vision 2 years after stereotactic radiosurgery for a presumed optic nerve sheath meningioma. J Neuroophthalmol, 18(2): 117-120.
22. LANDERT M, BAUMERT BG, BOSCH MM, LUTOLF UM, LANDAU K. (2005). The visual impact of fractionated stereotactic conformal radiotherapy on seven eyes with optic nerve sheath meningiomas. J Neuroophtalmol, 25(2): 86-91.
23. LEE AG, WOO SY, MILLER NR, SAFRAN AB, GRANT WH, BUTLER EB. (1996). Improvement in visual function in an eye with a presumed optic nerve sheath meningioma after treatment with tree-dimensional conformal radiation therapy. J Neuro-ophtalmol, 16(4): 247-251.
24. LEE AG, LIN DJ, KAUFMAN M, GOLNIK KC, VAPHIADES MS, EGGENBERGER E. (2000). Atypical features prompting neuroimaging in acute optic neuropathy in adults. Can J Ophtalmol, 35(6): 325-330.
25. LIU JK, FORMAN S, HERSHEWE GL, MOORTHY CR, BENZIL DL. (2002). Optic nerve sheath meningiomas:visual improvement after stereotactic radiotherapy. Neurosurg, 50(5): 950-957.
26. MAFEE MF, GOODWIN J, DORODI S. (1999). Optic nerve sheath meningiomas. Role of MR imaging. Radiol Clin North Am, 37(1): 37-58.
27. MASON WP, GENTILI F, MCDONALD DR MICHELSEN JJ, NEW PFJ. (1969). Brain tumour and pregnancy. J Neurol Neurosurg Psychiatry, 32: 305-307.
28. MASON WP, GENTILI F, MACDONALD DR, HARIHARAN S, CRUZ CR, ABREY LE. (2002). Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma. J Neurosurg, 97(2): 341-346.
29. MILLER NR. (2004). Primary tumours of the optic nerve and its sheath. Eye, 18(11): 1026-1037.
30. MOYER PD, GOLNIK KC, BRENEMAN J. (2000). Treatment of optic nerve sheath meningioma with tree-dimentional conformal radiation. Am J Ophtalmol, 129: 694-696.
31. NARAYAN S, CORNBLATH WT, SANDLER HM, ELNER V, HAYMAN JA. (2003). Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningioma. Int J Radiation Biol Phys, 56(2): 537-543.
32. ORCUTT JC, TUCKER WM, MILLS RP, SMITH CH. (1987). Gaze-evoked amaurosis. Ophtalmology, 94(3): 213-218.
33. OURA S, SAKURAI T, YOSHIMURA G et al. (2000). Regression of a presumed meningioma with the antiestrogen agent mepitiostane. Case report. J Neurosurg, 93(1): 132-135.
34. PARIDAENS ADA, VAN RUYVEN RLJ, EIJKENBOOM WMH, MOOY CM, VAN DEN BOSCH WA (2003). Stereotactic irradiation of biopsy proved optic nerve sheath meningioma. Br J Ophtalmol, 87(2): 246-247.
35. PAUS S, T KLOCKGETHER, U SCHLEGEL, H URBACH. (2003). Meningioma of the optic nerve sheath: treatment with hydroxyurea. J Neurol Neurosurg Psychiatry, 74: 1348-1349.
36. PITZ S, BECKER G, SCHIEFER U et al. (2002). Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative. Br J Ophtalmol, 86: 1265-1268.
37. RICHARDS JC, RODEN D, HARPER CS. (2005). Management of sightthreatening optic nerve sheath meningioma with fractionated stereotactic radiotherapy. Clin Experiment Ophtalmol, 33(2): 137-141.
38. ROSENTHAL MA, ASHLEY DL, CHER L. (2002). Treatment of high risk or recurrent meningiomas with hydroxyurea. J Clin Neurosci, 9: 156-158.
39. SAEED P, ROOTMAN J, NUGENT RA, WHITE VA, MACKENZIE IR, KOORNEEF L. (2003). Optic nerve sheath meningiomas. Ophtalmology, 110(10): 2019-2029.
40. SARKIES NJC. (1987). Optic nerve sheath meningioma:diagnostic features and therapeutic alternatives. Eye, 1: 597-602.
41. SCHICK U, DOTT U, HASSLER W. (2004). Surgical management of meningiomas involving the optic nerve sheath. J Neurosurg, 101(6): 951-959.
42. SCHRELL UM, RITTIG MG, ANDERS M et al. (1997). Hydroxyurea for treatment of unresectable and recurrent meningiomas. J Neurosurg, 86(5): 845-852.
43. SHARIF S, BRENNAN P, RAWLUK. (1998). Non-surgical treatment of meningioma: a case report and review. Br J Neurosurg, 12(4): 369-372.
44. SIBONY PA, KRAUSS HR, KENNERDELL JS, MAROON JC, SLAMOVITS TL. (1984). Optic nerve sheath meningiomas. Ophtalmology, 91: 1313-1326.
45. SPENCER WH. (1972).Primary neoplasms of the optic nerve an dits sheaths: clinical features and current concepts of pathogenrtics mechanism. Trans Am Ophtalmol Soc, 70: 490-528.
46. SUBRAMIAN PS, BRESSLER NM, MILLER NR. (2004). Radiation retinopathy after fractionated stereotactic radiotherapy for optic nerve sheath meningioma. Ophtalmology, 111(3): 565-567.
47. SURAWICZ TS, MC CARTHY BJ, KUPELIAN V et al. (1999). Descriptive epidemiology of primary brain and CNS tumor registry of the united states, 1990-1994. Neuro-oncology, 1: 14-25.
48. SWENSON SA, KRAUSS HR, KENNERDELL JS, CAMPBELL RJ. (1982). Radiologic evaluation of tumors of the optic nerve. AJNR, 3: 319-326.
49. TURBIN RE, THOMPSON CR, KENNERDELL JS, PEELE COCKERHAM C, KUPERSMITH MJ. (2002). A long-term visual outcome comparison in patients with optic nerve sheath meningioma managed with observation, surgery, radiotherapy, or surgery and radiotherapy. Ophtalmology, 109(5): 890-9; discussion 899-900.
50. WALSH FB. (1975).Meningiomas, primary within the orbit and optic canal. In Glaser JS, Smith JL (eds), Neuro-ophtalmology, Saint-Louis, CV, Mosby. pp 66-190.
51. WRIGHT JE, CALL NB, LIARICOS S. (1980). Primary optic nerve sheath meningioma. Br J Ophtalmol, 64: 553-558.
52. WRIGHT J, MCNAB AA, MCDONALD WI. (1989). Primary optic nerve sheath meningioma. Br J Ophtalmol, 73: 960-966.
53. YUCEER N, ERDOGAN A, ZIYA H. (1994). Primary optic nerve sheath meningiomas. Report of seven cases (clinical neuroradiological, pathological and surgical considerations in seven cases). J Neurosurg Sci, 38(3): 155-159.
54. ZIMMERMAN CF, SCHATZ NJ, GLASER JS. (1990). Magnetic resonance imaging of optic nerve meningiomas. Enhancement with gadolinium-DTPA. Ophtalmol, 97(5): 585-591.